Severe Liver Cirrhosis Markedly Reduces AhR-Mediated Induction of Cytochrome P450 in Rats by Decreasing the Transcription of Target Genes

被引:13
作者
Floreani, Maura [1 ]
De Martin, Sara [1 ]
Gabbia, Daniela [1 ]
Barbierato, Massimo [1 ]
Nassi, Alberto [1 ]
Mescoli, Claudia [2 ]
Orlando, Rocco [3 ]
Bova, Sergio [3 ]
Angeli, Paolo [3 ]
Gola, Elisabetta [3 ]
Sticca, Antonietta [3 ]
Palatini, Pietro [1 ]
机构
[1] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy
[2] Univ Padua, Dept Med, Surg Pathol & Cytopathol Unit, Padua, Italy
[3] Univ Padua, Dept Med, Lab Expt Hepatol, Padua, Italy
关键词
DRUG-METABOLIZING-ENZYMES; ARYL-HYDROCARBON RECEPTOR; PROTEIN-BINDING DISPLACEMENT; IN-VIVO; DISEASE; EXPRESSION; MICROSOMES; DYSFUNCTION; INHIBITION; ASCITES;
D O I
10.1371/journal.pone.0061983
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Although the induction of cytochrome P450 (CYP) has long been investigated in patients with cirrhosis, the question whether liver dysfunction impairs the response to CYP inducers still remains unresolved. Moreover, the mechanism underlying the possible effect of cirrhosis on induction has not been investigated. Since ethical constraints do not permit methodologically rigorous studies in humans, this question was addressed by investigating the effect of the prototypical inducer benzo[a] pyrene (BP) on CYP1A1 and CYP1A2 in cirrhotic rats stratified according to the severity of liver dysfunction. We simultaneously assessed mRNA level, protein expression and enzymatic activity of the CYP1A enzymes, as well as mRNA and protein expressions of the aryl hydrocarbon receptor (AhR), which mediates the BP effect. Basal mRNA and protein expressions of CYP1A1 were virtually absent in both healthy and cirrhotic rats. On the contrary, CYP1A2 mRNA, protein and enzyme activity were constitutively present in healthy rats and decreased significantly as liver function worsened. BP treatment markedly increased the concentrations of mRNA and immunodetectable protein, and the enzymatic activities of both CYP1A enzymes to similar levels in healthy and non-ascitic cirrhotic rats. Induced mRNA levels, protein expressions and enzymatic activities of both CYPs were much lower in ascitic rats and were proportionally reduced. Both constitutive and induced protein expressions of AhR were significantly lower in ascitic than in healthy rats. These results indicate that the inducibility of CYP1A enzymes is well preserved in compensated cirrhosis, whereas it is markedly reduced when liver dysfunction becomes severe. Induction appears to be impaired at the transcriptional level, due to the reduced expression of AhR, which controls the transcription of CYP1A genes.
引用
收藏
页数:10
相关论文
共 36 条
[1]   CYTOCHROME-P450 SPECIFICITIES OF ALKOXYRESORUFIN O-DEALKYLATION IN HUMAN AND RAT-LIVER [J].
BURKE, MD ;
THOMPSON, S ;
WEAVER, RJ ;
WOLF, CR ;
MAYER, RT .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (05) :923-936
[2]  
Copeland RA, 2000, ENZYMES PRACTICAL IN
[3]   The effect of liver cirrhosis on the regulation and expression of drug metabolizing enzymes [J].
Elbekai, RH ;
Korashy, HM ;
El-Kadi, AOS .
CURRENT DRUG METABOLISM, 2004, 5 (02) :157-167
[4]  
Farrell G, 1999, Mol Aspects Med, V20, P55
[5]   MICROSOMAL PROTEIN-SYNTHESIS AND INDUCTION OF CYTOCHROME-P-450 IN CIRRHOTIC RAT-LIVER [J].
FARRELL, GC ;
ZALUZNY, L .
AUSTRALIAN JOURNAL OF EXPERIMENTAL BIOLOGY AND MEDICAL SCIENCE, 1984, 62 (JUN) :291-301
[6]   Differential Inducing Effect of Benzo[a]pyrene on Gene Expression and Enzyme Activity of Cytochromes P450 1A1 and 1A2 in Sprague-Dawley and Wistar Rats [J].
Floreani, Maura ;
Gabbia, Daniela ;
Barbierato, Massimo ;
De Martin, Sara ;
Palatini, Pietro .
DRUG METABOLISM AND PHARMACOKINETICS, 2012, 27 (06) :640-652
[7]   In vivo up-regulation of aryl hydrocarbon receptor expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in a dioxin-resistant rat model [J].
Franc, MA ;
Pohjanvirta, R ;
Tuomisto, J ;
Okey, AB .
BIOCHEMICAL PHARMACOLOGY, 2001, 62 (12) :1565-1578
[8]   Induction of drug metabolising enzymes - Pharmacokinetic and toxicological consequences in humans [J].
Fuhr, U .
CLINICAL PHARMACOKINETICS, 2000, 38 (06) :493-504
[9]   PRETRANSLATIONAL REGULATION OF CYTOCHROME-P450 GENES IS RESPONSIBLE FOR DISEASE-SPECIFIC CHANGES OF INDIVIDUAL P450 ENZYMES AMONG PATIENTS WITH CIRRHOSIS [J].
GEORGE, J ;
LIDDLE, C ;
MURRAY, M ;
BYTH, K ;
FARRELL, GC .
BIOCHEMICAL PHARMACOLOGY, 1995, 49 (07) :873-881
[10]  
GEORGE J, 1995, HEPATOLOGY, V21, P120, DOI 10.1016/0270-9139(95)90418-2